Get started
Author

David Johnson

Observed names: D Johnson, D. Johnson, David R Johnson, David Ross Johnson, Johnson, David.
Observed institutions: Centers for Disease Control and Prevention, Lovelace Respiratory Research Institute, Mayo Clinic, Duke University, Chinese University of Hong Kong, Prince of Wales Hospital, Prince of Wales Hospital, Aboriginal Health Council of South Australia
ORCID: 0000-0001-6932-2460
Observed ORCID: 0000-0001-6932-2460
OpenAlex ID: A5027984334
Nasopharyngeal carcinoma: an evolving paradigm
2021 · Kenneth C. W. Wong, Edwin P. Hui, et al. · Nature Reviews Clinical Oncology · 549
Measuring the Burden of Health Care Costs on US Families
2017 · Ezekiel J. Emanuel, Aaron Glickman, et al. · JAMA · 54
Targeting the PD-1/ PD-L1 interaction in nasopharyngeal carcinoma
2021 · David Johnson, Brigette B.Y. Ma · Oral Oncology · 49
Current advances in targeted therapy for metastatic colorectal cancer – Clinical translation and future directions
2024 · David Johnson, Cheng Ean Chee, et al. · Cancer Treatment Reviews · 45
Opportunities and challenges in combining immunotherapy and radiotherapy in head and neck cancers
2022 · Kenneth C.W. Wong, David Johnson, et al. · Cancer Treatment Reviews · 39
A randomized clinical trial of an interactive voice response and text message intervention for individuals with hypertension
2020 · Emily B. Schroeder, Kelly R. Moore, et al. · Journal of Clinical Hypertension · 36
PDF
Supporting Aboriginal Community Controlled Health Services to deliver alcohol care: protocol for a cluster randomised controlled trial
2019 · Kristie H Harrison, KS Kylie Lee, et al. · BMJ Open · 20
PDF
Durability of the parotid‐sparing effect of intensity‐modulated radiotherapy ( IMRT ) in early stage nasopharyngeal carcinoma: A 15‐year follow‐up of a randomized prospective study of IMRT versus two‐dimensional radiotherapy
2021 · Darren M. C. Poon, Michael K. M. Kam, et al. · Head & Neck · 19
Support can increase use of the AUDIT‐C in Australian Aboriginal Community Controlled Health Services: a cluster randomized trial
2021 · James H. Conigrave, Kristie H. Harrison, et al. · Addiction · 16
Characteristics of Indigenous adults with poorly controlled diabetes in north Queensland: implications for services
2015 · David Ross Johnson, Robyn Anne McDermott, et al. · BMC Public Health · 11
PDF
An Interactive Voice Response and Text Message Intervention to Improve Blood Pressure Control Among Individuals With Hypertension Receiving Care at an Urban Indian Health Organization: Protocol and Baseline Characteristics of a Pragmatic Randomized Controlled Trial
2019 · Emily B Schroeder, Kelly Moore, et al. · JMIR Research Protocols · 9
Total Neoadjuvant Therapy for High Risk Rectal Cancer in Western and Asian Populations – Current Evidence and Clinical Applications
2021 · David Johnson, Leung Li, et al. · Clinical Colorectal Cancer · 8
The efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: A phase III randomized, double blind, placebo-controlled NCCTG trial, N01C3
2006 · S. I. Renno, R. D. Rao, et al. · Journal of Clinical Oncology · 7
247 Phase III study comparing chemotherapy and radiation therapy with preoperative chemotherapy and surgical resection in patients with non-small cell lung cancer (NSCLC) with spread to mediastinal lymph nodes (N2): A radiation therapy oncology group study (RTOG 89-01)
1997 · R. Inculet, C. Scott, et al. · Lung Cancer · 7
Pattern of failure, impact of local therapy, and characteristics of long-term responders with advanced EGFR mutation positive non-small cell lung cancer treated with first-line osimertinib
2025 · Allen C.C. Chen, Florence S.T. Mok, et al. · Lung Cancer · 6
CNS Outcomes of Osimertinib Plus Chemotherapy in Patients With EGFR Mutation Positive Lung Cancer Beyond Osimertinib Progression
2025 · Wesley K.Y. Wong, Kevin K.S. Mok, et al. · Clinical Lung Cancer · 6
Clinical applications of circulating tumor-derived DNA in the management of gastrointestinal cancers – current evidence and future directions
2022 · Rachel C. T. Lam, David Johnson, et al. · Frontiers in Oncology · 5
PDF
An Epidemiologic Approach to the Study of Aerosolized Florida Red Tides.
2004 · Lora E Fleming, Lorraine C Backer, et al. · PubMed · 4
Chronic hepatitis B management in six South Australian Aboriginal community controlled health services
2022 · Michael Larkin, Mohammad Mahmood, et al. · Australian Journal of Primary Health · 3
Racial and Ethnic Equity in Care for Hypertension and Diabetes in an Urban Indian Health Organization
2022 · Kelly R. Moore, Emily B. Schroeder, et al. · Journal of Racial and Ethnic Health Disparities · 3
126 Factors which influence quality of life in patients with non-small cell lung cancer (NSCLC): A radiation therapy oncology group study (RTOG 89-01)
1997 · C.B. Scott, W.T. Sause, et al. · International Journal of Radiation Oncology*Biology*Physics · 3
PDF
Continuity of Care and Health Decline Associated With a Hip Fracture
2002 · Marilyn Cree, Qian Yang, et al. · Journal of Aging and Health · 2
Abstract No. 181 Clinical Outcomes and Imaging Follow-Up in Patients with Acute Massive Pulmonary Embolism Treated with First-Line Aspiration Thrombectomy: A Retrospective Study
2024 · E. Barral, J. Martin, et al. · Journal of Vascular and Interventional Radiology · 1
Prevention of docetaxel-associated febrile neutropenia with primary granulocyte colony-stimulating factors (GCSF) in Chinese metastatic hormonal-sensitive (mHSPC) and castration-resistant prostate cancer (mCRPC).
2020 · Darren M.C. Poon, Kuen Chan, et al. · Journal of Clinical Oncology · 1
Introduction: the emerging roles of gemcitabine and MTA in the treatment of non-small cell lung cancer.
1999 · D Johnson, M Tonato · PubMed · 1
Works count: 41
Citation count: 905
H-index: 10
I10-index: 10
Year
Topic
Type